WVP
PDSB icon

Worth Venture Partners’s PDS Biotechnology PDSB Stock Holding History

Worth Venture Partners’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-70,378
Closed -$436K – 171
2022
Q1 		$436K Sell
70,378
-425
-0.6% -$2.64K 0.2% 87
2021
Q4 		$574K Sell
70,803
-106,786
-60% -$1.15M 0.28% 79
2021
Q3 		$2.65M Sell
177,589
-171,114
-49% -$2.13M 1.19% 29
2021
Q2 		$4.38M Buy
+348,703
New +$2.72M 1.63% 21
2020
Q2 		– Sell
-162,000
Closed -$118K – 136
2020
Q1 		$118K Buy
+162,000
New +$281K 0.07% 86

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Worth Venture Partners's PDSB Position: Q2 2022 in Review

Worth Venture Partners sold out of PDS Biotechnology (PDSB) in Q2 2022, closing a stake of 70,378 shares — an estimated $436K sold.

Worth Venture Partners first reported a position in PDSB in Q1 2020 and held it in 5 quarters. The position peaked at $4.38M in Q2 2021. 51 funds tracked by Wall St. Rank hold PDSB as of Q2 2022.

  • Worth Venture Partners reported no remaining PDS Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Worth Venture Partners sold 70,378 PDS Biotechnology shares in Q2 2022, an estimated $436K.
  • Worth Venture Partners first reported a position in PDS Biotechnology in Q1 2020 and held it in 5 quarters.
  • Worth Venture Partners's PDS Biotechnology position peaked at $4.38M in Q2 2021.
  • 51 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2022.

Based on Worth Venture Partners's 13F filing for Q2 2022, filed 15 Aug 2022.